2nd DECENTRALIZED & HYBRID CLINICAL TRIALS WORLD CONGRESS 2026 EUROPE
Redefining Clinical Research Through Decentralization, Technology, and Collaboration
London, United Kingdom
Day 2 - Thursday 26th February 2026
TECHNOLOGY, OPERATIONS AND FUTURE OUTLOOK
- Coordinating logistics and remote data management across borders
- Streamlining patient recruitment and local lab partnerships
- Managing supply chain complexities for home-delivered IMPs
- Remote monitoring and investigator coordination best practices
- Harmonizing operational standards under EMA oversight
- Scalable cloud-based data environments and interoperability
- AI-driven analytics and decentralized workflow automation
- Building resilient digital ecosystems for global research
- Standardizing APIs and digital identity systems for trial access
- Accessing national health data repositories under EHDS regulations
- Linking EHR and ePRO data to enhance endpoint validation
- Addressing data ownership and consent portability across borders
- Practical outcomes from Nordic and Benelux pilot programs
- Competency frameworks for investigators and monitors in DCTs
- EU-wide accreditation for digital trial operations training
- Adapting site culture to hybrid and remote collaboration
- Incentivizing ongoing digital literacy and skill development
- Expanding inclusive strategies to improve DCT participation across Europe.
- Embedding AI and digital tools into modern trial planning.
- Identifying savings from reduced site visits and remote operations.
- Balancing tech investment with patient engagement costs.
- Tracking shifts toward adaptive, risk-based DCT budgeting.
- Showcases of compliant digital platforms and wearables
- Evaluation criteria for security, usability, and interoperability
- Integration success stories from EU-funded collaborations
- Discussion with vendors and regulators on platform certification
- Streamlining submissions under the CTR multi-member review model
- Ensuring eConsent accessibility across languages and literacy levels
- Handling withdrawal and re-consent procedures under GDPR
- Aligning local ethics boards under unified EU ethical frameworks
- Using remote models to connect geographically dispersed patients
- Overcoming recruitment challenges through decentralized access
- Leveraging telemedicine and home sampling for small populations
- Case outcomes from recent EU-funded rare disease initiatives
- How can collaboration between regulators, industry, and academia accelerate DCT innovation across
Europe? - What funding and infrastructure models best support large-scale decentralized trial adoption?
- How can shared digital platforms improve data interoperability and transparency?
- What role will EU initiatives like Horizon Europe and IMI play in sustaining long-term DCT growth?
- How are decentralized trials evolving from pilot initiatives to Europe’s new research standard?
- How can decentralized models be effectively integrated with national healthcare systems?
- How can AI and real-world data enhance adaptive and data-driven study design?
- How can transparency and data ownership strengthen patient trust and engagement?
- How will decentralized trials become a core pillar of the European Health Union?
Moderator:
Panelists:
Co-located with Patient Centricity & Collaboration World Congress 2026 Europe.
Joint Networking & Exhibit Area.
